权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Inflammation and hepatic lipid metabolism

炎症与肝脏脂质代谢

基本信息

批准号：
10649651
负责人：
ALAN R. SALTIEL
金额：
$ 52.54万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-07-01 至 2024-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10649651
关键词：
Acute Adaptor Signaling Protein Affinity Apoptosis Apoptotic Attention Binding Biological CASP6 gene CRISPR/Cas technology Cells Cessation of life Coenzyme A Ligases Complex Data Diabetes Mellitus Diet Disease Ensure Enzymes Epidemic Equilibrium Esterification Event Exhibits Family member Fasting Fatty Acids Fatty Liver Fatty acid glycerol esters Gene Expression Genetic Transcription Hepatic Hepatitis Hepatocyte High Fat Diet Homeostasis Human In Vitro Inflammation Inflammatory Insulin Resistance Investigation Knock-in Knock-out Knockout Mice Link Lipids Liver Metabolic Metabolism Microsomes Mitochondria Molecular Molecular Conformation Mus Mutation Analysis Nature Obese Mice Obesity Obesity Epidemic Outer Mitochondrial Membrane Pathology Pathway interactions Patients Phosphoric Monoester Hydrolases Phosphorylation Phosphotransferases Process Protein Dephosphorylation Protein Family Protein Kinase Proteins Regulation Repression Role Scaffolding Protein Serine Signal Transduction Site Starvation TBK1 gene Threonine Time Uncertainty amlexanox cytokine derepression energy balance fatty acid oxidation improved in vivo inhibitor lipid metabolism liver injury mimetics mutant non-alcoholic non-alcoholic fatty liver disease novel therapeutic intervention oxidation prevent programs reconstitution recruit restoration upstream kinase

项目摘要

Abstract There is little doubt that we are in the midst of a worldwide epidemic of obesity and diabetes. Among the many complications of obesity is fatty liver, and its associated disease Nonalcoholic Steatotic Hepatitis (NASH). However, the manner by which lipid storage and oxidation is controlled in liver is only partly understood. We hypothesize that inflammation plays a role in this process through the protein kinase TBK1. TBK1 associates with the key enzyme ACSL1, localizing it to mitochondria for fatty acid oxidation during starvation, and to ER for fatty acid re-esterification during obesity. Moreover, TBK1 represses the activity of AMPK during obesity, linking fatty liver to liver damage. We will explore the nature of these pathways with three aims: 1) We will elucidate the temporal and spatial aspects of the induction and activation of the kinase TBK1 in fasting and obesity; 2) We will deeply explore the molecular mechanism involved in its interaction with ACSL1; and 3) We will evaluate the molecular mechanisms whereby TBK1 reduces the activity of AMPK, and how this results in hepatocellular death and liver damage.

摘要毫无疑问，我们正处于肥胖和糖尿病的全球流行之中。在众多肥胖症的并发症是脂肪肝及其相关疾病非酒精性脂肪性肝炎（NASH）。然而，在肝脏中控制脂质储存和氧化的方式仅部分了解。我们假设炎症通过蛋白激酶TBK 1在此过程中发挥作用。TBK 1联营公司与关键酶ACSL 1，定位于线粒体的脂肪酸氧化在饥饿期间，和ER 脂肪酸再酯化的作用。此外，TBK 1在肥胖期间抑制AMPK的活性，脂肪肝与肝损伤之间的联系我们将探索这些途径的性质，有三个目标：1）我们将阐明禁食和禁食中激酶TBK 1的诱导和激活的时间和空间方面，肥胖; 2）我们将深入探讨其与ACSL 1相互作用的分子机制; 3）我们将将评估TBK 1降低AMPK活性的分子机制，以及这如何导致肝细胞死亡和肝损伤。